NCT02638337View on ClinicalTrials.gov

Study to Evaluate Ospemifene in Patients With Moderate to Severe Vaginal Dryness Due to Menopause

PHASE3CompletedINTERVENTIONAL
Enrollment

631

Participants

Timeline

Start Date

January 26, 2016

Primary Completion Date

June 23, 2017

Study Completion Date

July 5, 2017

Conditions
Vaginal Dryness
Interventions
DRUG

Ospemifene

60 mg tablet

DRUG

Placebo

Tablet identical to the ospemifene tablet without drug

Sponsors

Lead Sponsor

Shionogi
All Listed Sponsors
lead

Shionogi

INDUSTRY